Thorsten Waloschek: 3D-Bioprinted Placentas Could Predict and Prevent Preeclampsia
Thorsten Waloschek, CEO at NeoPredics AG, shared a post on LinkedIn:
“Scientists in Sydney have 3D-bioprinted miniature placentas – a breakthrough that could transform how we understand pregnancy complications like preeclampsia.
Until now, studying the early placenta has been almost impossible. By the time a baby is born, the organ looks very different from its first-trimester state, and animal models don’t capture the unique biology of humans. Bioprinting changes that. Researchers can now grow organoids that closely mimic early placental tissue, expose them to stressors linked to preeclampsia, and even test potential therapies.
It is still early days, but this feels like a leap toward a future where complications in pregnancy could be predicted, prevented, or treated before they put lives at risk. Advances like this remind us how much innovation in bioengineering can ripple far beyond the lab, reshaping the health of generations to come.”
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic